高级检索
当前位置: 首页 > 详情页

A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd. [2]The First Affiliated Hospital of Wannan Medical College,Wuhu,Anhui,China,241000 [3]Dermatology Hospital, Southern Medical University,Guangzhou,Guangdong,China,510030 [4]The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China,510260 [5]Shenzhen People's Hospital,Shenzhen,Guangdong,China,518020 [6]Affiliated Hospital of Guilin Medical University,Guilin,Guangxi,China,541001 [7]Affiliated Hospital of Hebei Engineering University,Handan,Hebei,China,056002 [8]The Forth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China,050000 [9]The second affiliated hospital of harbin medical university,Harbin,Heilongjiang,China,150000 [10]Puyang District Hospital of Anyang City,Anyang,Henan,China,455000 [11]The First People's Hospital of Nanyang,Nanyang,Henan,China,473000 [12]People's Hospital of Henan province,Zhengzhou,Henan,China,450003 [13]Shiyan Renmin Hospital,Shiyan,Hubei,China,442000 [14]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430000 [15]The third xiangya hospital of central south university,Changsha,Hunan,China,410013 [16]Qian-jin Lu,Nanjing,Jiangsu,China,210042 [17]Affiliated Hospital of Jiujiang University,Jiujiang,Jiangxi,China,332000 [18]The Second Hospital of Jilin University,Changchun,Jilin,China,130041 [19]Panjin Liaoyou Gem Flower Hospital,Panjin,Liaoning,China,124000 [20]The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,China,110000 [21]Air Force Medical University,Xi'an,Shaanxi,China,710032 [22]The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,China,710061 [23]Shengli Oil Field Central Hospital,Dongying,Shandong,China,25700 [24]Shandong First Medical University Affiliated Dermatology Hospital,Jinan,Shandong,China,250022 [25]Qilu Hospital of Shandong University,Jinan,Shandong,China,250063 [26]The Affiliated Hospital Of Qingdao University,Qingdao,Shandong,China,266000 [27]Huashan Hospital Affiliated to Fudan University,Shanghai,Shanghai,China,200040 [28]Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital,Tianjin,Tianjin,China,300122 [29]Xinjiang Uygur Autonomous Region People's Hospital,Ürümqi,Xinjiang Uygur Autonomous Region,China,830000 [30]The First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China,650000 [31]The First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310003 [32]The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310009 [33]The First People's Hospital of Wenling,Wenling,Zhejiang,China,317500

研究目的:
This phase II clinical trials is multicenter, randomized, double-blind, placebo-controlled to assess the effectiveness and safety of TQH2722 injection in the treatment of subjects with moderate to severe atopic dermatitis.

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)